JP2012526846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526846A5 JP2012526846A5 JP2012511015A JP2012511015A JP2012526846A5 JP 2012526846 A5 JP2012526846 A5 JP 2012526846A5 JP 2012511015 A JP2012511015 A JP 2012511015A JP 2012511015 A JP2012511015 A JP 2012511015A JP 2012526846 A5 JP2012526846 A5 JP 2012526846A5
- Authority
- JP
- Japan
- Prior art keywords
- tgf
- antibody
- human
- composition
- regulatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17792409P | 2009-05-13 | 2009-05-13 | |
| US61/177,924 | 2009-05-13 | ||
| PCT/US2010/034741 WO2010132683A1 (en) | 2009-05-13 | 2010-05-13 | Methods and compositions for treating lupus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014250861A Division JP2015052021A (ja) | 2009-05-13 | 2014-12-11 | ループス治療のための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012526846A JP2012526846A (ja) | 2012-11-01 |
| JP2012526846A5 true JP2012526846A5 (enExample) | 2013-06-27 |
| JP5834004B2 JP5834004B2 (ja) | 2015-12-16 |
Family
ID=43085330
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012511015A Active JP5834004B2 (ja) | 2009-05-13 | 2010-05-13 | ループス治療のための方法および組成物 |
| JP2014250861A Withdrawn JP2015052021A (ja) | 2009-05-13 | 2014-12-11 | ループス治療のための方法および組成物 |
| JP2016197833A Pending JP2017008106A (ja) | 2009-05-13 | 2016-10-06 | ループス治療のための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014250861A Withdrawn JP2015052021A (ja) | 2009-05-13 | 2014-12-11 | ループス治療のための方法および組成物 |
| JP2016197833A Pending JP2017008106A (ja) | 2009-05-13 | 2016-10-06 | ループス治療のための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9617343B2 (enExample) |
| EP (2) | EP3345620B1 (enExample) |
| JP (3) | JP5834004B2 (enExample) |
| KR (1) | KR101800467B1 (enExample) |
| CN (2) | CN110179989B (enExample) |
| AU (2) | AU2010248935B2 (enExample) |
| BR (1) | BRPI1013927A2 (enExample) |
| CA (1) | CA2761885A1 (enExample) |
| IL (1) | IL216146A0 (enExample) |
| MX (1) | MX342907B (enExample) |
| RU (1) | RU2607022C2 (enExample) |
| WO (1) | WO2010132683A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011012047A (es) | 2009-05-13 | 2011-12-14 | Genzyme Corp | Inmunoglobulinas humanas anti-cd52. |
| WO2013107413A1 (zh) * | 2012-01-19 | 2013-07-25 | 中国科学院上海巴斯德研究所 | 磷酸化途径相关因子在调控调节性t细胞功能中的应用 |
| RU2019103573A (ru) * | 2013-02-08 | 2019-03-15 | Аллегени-Сингер Рисерч Инститьют | Клеточно-связанные продукты активации комплемента в качестве диагностических биомаркеров волчанки в доклинической стадии |
| AR095199A1 (es) | 2013-03-15 | 2015-09-30 | Genzyme Corp | Anticuerpos anti-cd52 |
| CA2899835A1 (en) * | 2013-03-20 | 2014-09-25 | F. Hoffmann-La Roche Ag | Specific detection of rat antibodies in mouse serum |
| DK3105317T3 (en) * | 2014-02-14 | 2019-01-14 | Cellectis | Immunotherapy cells that are genetically engineered to target antigen on both immune cells and pathological cells |
| CA2977106A1 (en) * | 2015-02-27 | 2016-09-01 | Icell Gene Therapeutics Llc | Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof |
| TWI833684B (zh) | 2015-06-25 | 2024-03-01 | 美商生物細胞基因治療有限公司 | 嵌合抗原受體（ｃａｒ）、組合物及其使用方法 |
| US11173179B2 (en) | 2015-06-25 | 2021-11-16 | Icell Gene Therapeutics Llc | Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof |
| CN109562126A (zh) | 2016-06-24 | 2019-04-02 | 美商生物细胞基因治疗有限公司 | 嵌合抗原受体(car)、组合物及其使用方法 |
| CN118853581A (zh) | 2017-06-21 | 2024-10-29 | 美商生物细胞基因治疗有限公司 | 嵌合抗原受体(CARs)、组合物及其使用方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9022543D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Antibody production |
| GB9022547D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Purified immunoglobulin |
| GB9125768D0 (en) | 1991-12-04 | 1992-02-05 | Hale Geoffrey | Therapeutic method |
| US7119248B1 (en) | 1994-04-12 | 2006-10-10 | Miltenyi Biotec Gmbh | Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
| US7060802B1 (en) * | 2000-09-18 | 2006-06-13 | The Trustees Of Columbia University In The City Of New York | Tumor-associated marker |
| US7465790B2 (en) | 2000-10-09 | 2008-12-16 | Isis Innovation, Inc. | Therapeutic antibodies |
| US20050191632A1 (en) * | 2002-11-01 | 2005-09-01 | John Byrd | Cytogenetic abnormalities that are predictive of response to therapy for chronic lymphocytic leukemia |
| US7534427B2 (en) | 2002-12-31 | 2009-05-19 | Immunomedics, Inc. | Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| KR20060002896A (ko) | 2003-03-31 | 2006-01-09 | 기린 비루 가부시키가이샤 | 항 ｃｄ52 항체에 의한 조절성 ｔ 세포 분화 유도ㆍ증식방법 및 그를 위한 의약 조성물 |
| EP1694706B1 (en) | 2003-11-01 | 2012-04-04 | Merck Patent GmbH | Modified anti-cd52 antibody |
| AU2005249360B2 (en) | 2004-04-12 | 2011-07-21 | Medimmune, Llc | Anti-IL-9 antibody formulations and uses thereof |
| CN101443040A (zh) * | 2006-03-16 | 2009-05-27 | 基因技术股份有限公司 | 用cd4抗体治疗狼疮的方法 |
| JP2009533350A (ja) | 2006-04-07 | 2009-09-17 | キメロス， インコーポレイテッド | Ｂ細胞悪性疾患を処置するための組成物および方法 |
| WO2007121233A1 (en) * | 2006-04-12 | 2007-10-25 | Genzyme Corporation | Methods of treating autoimmune diseases |
| GB0608054D0 (en) * | 2006-04-24 | 2006-05-31 | Isis Innovation | Production and use of regulatory t cells |
| US20100034782A1 (en) * | 2006-05-31 | 2010-02-11 | Nader Najafian | Methods of Using Anti-Thymocyte Globulin and Related Agents |
| DK2046809T3 (en) * | 2006-07-19 | 2017-03-13 | Univ Pennsylvania | WSX-1 / IL-27 AS A TARGET OBJECTIVE FOR ANTI-INFLAMMATORY REACTIONS |
| EP2102367A2 (en) | 2006-11-09 | 2009-09-23 | XDX, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| MX2011012047A (es) * | 2009-05-13 | 2011-12-14 | Genzyme Corp | Inmunoglobulinas humanas anti-cd52. |
| AR095199A1 (es) | 2013-03-15 | 2015-09-30 | Genzyme Corp | Anticuerpos anti-cd52 |
-
2010
- 2010-05-13 BR BRPI1013927A patent/BRPI1013927A2/pt not_active Application Discontinuation
- 2010-05-13 WO PCT/US2010/034741 patent/WO2010132683A1/en not_active Ceased
- 2010-05-13 CA CA2761885A patent/CA2761885A1/en not_active Withdrawn
- 2010-05-13 RU RU2011150495A patent/RU2607022C2/ru active
- 2010-05-13 AU AU2010248935A patent/AU2010248935B2/en active Active
- 2010-05-13 KR KR1020117029688A patent/KR101800467B1/ko active Active
- 2010-05-13 US US13/320,001 patent/US9617343B2/en active Active
- 2010-05-13 EP EP17206028.7A patent/EP3345620B1/en active Active
- 2010-05-13 MX MX2011012048A patent/MX342907B/es active IP Right Grant
- 2010-05-13 JP JP2012511015A patent/JP5834004B2/ja active Active
- 2010-05-13 EP EP10775545.6A patent/EP2429583A4/en not_active Withdrawn
- 2010-05-13 CN CN201910644240.8A patent/CN110179989B/zh active Active
- 2010-05-13 CN CN2010800209534A patent/CN102438654A/zh active Pending
-
2011
- 2011-11-03 IL IL216146A patent/IL216146A0/en active IP Right Grant
-
2014
- 2014-12-11 JP JP2014250861A patent/JP2015052021A/ja not_active Withdrawn
-
2016
- 2016-10-06 JP JP2016197833A patent/JP2017008106A/ja active Pending
-
2017
- 2017-03-01 US US15/446,162 patent/US20170369583A1/en not_active Abandoned
- 2017-03-15 AU AU2017201771A patent/AU2017201771A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011150495A (ru) | Способы и композиции для лечения волчанки | |
| RU2018110647A (ru) | Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний | |
| JP2006501240A5 (enExample) | ||
| JP2016074740A5 (enExample) | ||
| TW200806318A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
| WO2006008639A8 (en) | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody | |
| HK1202776A1 (en) | Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy | |
| DE60022021D1 (de) | Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion | |
| JP2019521156A5 (enExample) | ||
| JP2010530902A (ja) | 流涎症治療のためのグリコピロレートを含む経皮送達システム | |
| JOP20190019A1 (ar) | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) | |
| JP4272885B2 (ja) | コカイン依存症治療用薬剤 | |
| JP6770091B2 (ja) | ニコチン性アセチルコリン受容体アゴニストによる副鼻腔粘膜疾患を処置するための組成物及び方法 | |
| US6288026B1 (en) | Process and composition for treating diseases with an oil-in-water emulsion | |
| JP2024541122A (ja) | 疾患を治療するための免疫調節性物質を含む医薬組成物およびキット | |
| RU2403921C1 (ru) | Способ комбинированного лечения ограниченной склеродермии с применением локального трансдермального ферментативного электростатического воздействия | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| Ramakrishnan et al. | Treatment-related fluctuations in Guillain Barre syndrome and the conundrum of additional cycles of plasmapheresis | |
| RU2666942C1 (ru) | Способ лечения полинейромиопатии критических состояний у реанимационных больных | |
| Feagan et al. | P300 Health related quality of life results through week 22 from the CERTIFI study, a multicenter, randomized, double-blind, placebo-controlled Phase2b study of ustekinumab in patients with moderately to severely active Crohn's disease | |
| Dreschnack et al. | Case Report: Amyotrophic Lateral Sclerosis Treatment with Extracellular Vesicles derived from Mesenchymal Stromal Cells. Medical Research Archives,[online] 13 (9) | |
| JP2019511515A5 (enExample) | ||
| RU2266120C1 (ru) | Способ лечения негативных расстройств при шизофрении | |
| Osyanina | YOUNG PHARMACY-POTENTIAL OF THE FUTURE | |
| KR20170093704A (ko) | 면역글로불린 ｇ 제제의 피내 투여 |